Schedule 13G ownership disclosure

BOLT BIOTHERAPEUTICS INC

Common Stock, par value $0.00001 per share · CUSIP: 097702203

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Vivo Capital Fund VIII, L.P.

    Shares: 0.00 · Class: 0%

  • Vivo Capital Surplus Fund VIII, L.P.

    Shares: 0.00 · Class: 0%

  • Vivo Capital VIII, LLC

    Shares: 0.00 · Class: 0%

  • Vivo Panda Fund, L.P.

    Shares: 72,414.00 · Class: 3.8%

  • Vivo Panda, LLC

    Shares: 72,414.00 · Class: 3.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-26-016669
Form type
SCHEDULE 13G/A
Filer
Bolt Biotherapeutics, Inc.
CIK
CIK 1641281
Filed
Feb 13, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub